Cargando…
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
BACKGROUND: High prevalence of hepatocellular carcinoma (HCC) and typically poor prognosis of this disease that lead to late stage diagnosis when potentially curative therapies are least effective; therefore, development of an effective and systematic treatment is an urgent requirement. MAIN BODY: I...
Autores principales: | Hosseinzadeh, Faezeh, Verdi, Javad, Ai, Jafar, Hajighasemlou, Saieh, Seyhoun, Iman, Parvizpour, Frzad, Hosseinzadeh, Fatemeh, Iranikhah, Abolfazl, Shirian, Sadegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131874/ https://www.ncbi.nlm.nih.gov/pubmed/30214375 http://dx.doi.org/10.1186/s12935-018-0624-x |
Ejemplares similares
-
Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells
por: Seyhoun, Iman, et al.
Publicado: (2019) -
Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC
por: Hajighasemlou, Saieh, et al.
Publicado: (2020) -
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2019) -
Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies
por: Hajighasemlou, Saieh, et al.
Publicado: (2018) -
Anti‐inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model
por: Hajighasemlou, Saieh, et al.
Publicado: (2022)